The oral KIF11 inhibitor 4SC‐205 exhibits antitumor activity and potentiates standard and targeted therapies in primary and metastatic neuroblastoma models
暂无分享,去创建一个
A. Villanueva | M. Segura | R. Noguera | A. Santamaría | M. Oliván | D. Llobet-Navás | J. Roma | B. Majem | A. Soriano | S. Gallego | Rebeca Burgos-Panadero | J. Sánchez de Toledo | M. Masanas | C. Jiménez | Laura Devis-Jauregui | L. Moreno | G. Guillén | A. Boloix | R. Krauss | N. Masiá | Leticia Suárez-Cabrera | Pau Rodriguez‐Sodupe | Ignasi Toledano | Alexandra Navarro | R. Burgos-Panadero